Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia.

导出 OA

翻译打印收藏纠错

作者： Kei,Kushitani ^[1] ; Vishwa Jeet,Amatya ^[1] ; Amany Sayed,Mawas ^[2] ; Rui,Suzuki ^[1] ; Yoshihiro,Miyata ^[3] ; Morihito,Okada ^[3] ; Kouki,Inai ^[1] ; Takumi,Kishimoto ^[4] ; Yukio,Takeshima ^[1]

作者单位： Department of Pathology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan. ^[1] Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, South Valley University, Qena 83523, Egypt. ^[2] Department of Surgical Oncology, Research Center for Radiation Casualty Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8551, Japan. ^[3] Department of Internal Medicine, Okayama Rosai Hospital, Okayama 702-8055, Japan. ^[4]

关键词 BAP1 Ki-67 immunohistochemistry mesothelioma reactive mesothelial hyperplasia survivin

DOI 10.3892/ol.2018.7765

PMID 29467873

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交